Listed

Mannkind Corp

MNKDNasdaqCIK 899460HealthcareFiscal year ends Dec 31

Reports and events: 345 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Mannkind Corp, Reports and events
FiledFormWhat it isAccession number
2023-08-0716:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-039048
2023-07-0318:00 ET8-K8.01 Other events0000950170-23-031202
2023-05-3016:07 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-156575
2023-05-1021:00 ET8-K/A2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-019977
2023-05-0916:11 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-019668
2023-05-0916:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-019629
2023-04-1017:01 ETDEF 14AProxy statement0000950170-23-012308
2023-03-2716:18 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-080473
2023-02-2316:11 ET10-KAnnual reportPeriod 2022-12-310001564590-23-002309
2023-02-2316:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-23-002306
2022-11-0808:08 ET10-QQuarterly reportPeriod 2022-09-300001564590-22-036933
2022-11-0808:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-036932
2022-10-3106:02 ET8-K5.02 Departure or appointment of officers or directors0001564590-22-035783
2022-09-2616:30 ET8-K8.01 Other events0001564590-22-032286
2022-08-0916:09 ET10-QQuarterly reportPeriod 2022-06-300001564590-22-028753
2022-08-0916:04 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-028748
2022-05-2516:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001564590-22-021266
2022-05-2316:06 ET8-K2.03 New direct financial obligation; 8.01 Other events0001193125-22-157444
2022-05-1217:12 ET8-K5.07 Shareholder vote results0001564590-22-019928
2022-05-0516:39 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-018297
2022-05-0516:09 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-018245
2022-03-3009:05 ETDEF 14AProxy statementPeriod 2022-05-100000950123-22-003670
2022-02-2416:11 ET10-KAnnual reportPeriod 2021-12-310001564590-22-006702
2022-02-2416:06 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-22-006688
2022-01-1807:00 ET8-K8.01 Other events0001564590-22-001402
2021-12-2706:31 ET8-K8.01 Other events0001564590-21-061212
2021-11-0916:12 ET10-QQuarterly reportPeriod 2021-09-300001564590-21-055727
2021-11-0916:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-055708
2021-10-1816:02 ET8-K1.01 Entry into a material agreement; 8.01 Other events0001193125-21-301017
2021-09-2916:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-21-286744
2021-08-1616:15 ET8-K/A1.01 Entry into a material agreement0001193125-21-247740
2021-08-1617:36 ET8-K1.01 Entry into a material agreement0001564590-21-044367
2021-08-1116:11 ET10-QQuarterly reportPeriod 2021-06-300001564590-21-043433
2021-08-1116:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-043422
2021-06-1718:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-192308
2021-05-2506:06 ET8-K1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-21-171623
2021-05-1216:12 ET10-QQuarterly reportPeriod 2021-03-310001564590-21-026999
2021-05-1216:08 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-026988
2021-04-2606:07 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-21-130221
2021-04-0717:08 ETDEF 14AProxy statementPeriod 2021-05-200001140361-21-012028
2021-03-0506:06 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-21-070265
2021-02-2508:11 ET10-KAnnual reportPeriod 2020-12-310001564590-21-008440
2021-02-2508:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-21-008439
2020-12-3008:11 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-329209
2020-12-1008:13 ET8-K8.01 Other events0001193125-20-314442
2020-12-0717:08 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-20-311859
2020-12-0108:05 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-20-306330
2020-11-3016:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-20-305568
2020-11-0416:11 ET10-QQuarterly reportPeriod 2020-09-300001564590-20-050471
2020-11-0416:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-20-050460

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 10, 2026, 17:15 ET. Listed shows no prices and gives no investment advice.